Guaifenesin
NDC 24689-144, Guaifenesin, tablet, from APNAR PHARMA LP.
- Product NDC
- 24689-144
- Status
- Listed
- Labeler
- APNAR PHARMA LP
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24689-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN400 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24689-144-01 | 24689014401 | 100 TABLET in 1 BOTTLE (24689-144-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 24689014401
GET /v1/drugs/nadac/24689014401
Use it
Look up 24689-144 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24689-144 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24689-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.